BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies
Frost & Sullivan Manufacturing
AUGUST 28, 2024
The global biomanufacturing capacity gap and budget constraints have ignited the “The Fourth Revolutionary Wave of Biologics Manufacturing”, with production sites expanding towards million-liter scales. In this context, Contract Development and Manufacturing Organizations (CDMOs) have become key players in global biomanufacturing.
Let's personalize your content